Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Baltimore, MD
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Bay City, MI
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
McLaren Bay Region
mi
from
Bay City, MI
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Detroit, MI
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Mount Clemens, MI
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
McLaren Macomb
mi
from
Mount Clemens, MI
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Minneapolis, MN
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
New York, NY
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Cincinnati, OH
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Cincinnati VA Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Cleveland, OH
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
VA Medical Center - Cleveland Louis Stokes
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Cleveland, OH
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Cleveland, OH
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Dayton, OH
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Tulsa, OK
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Oklahoma Heart Institute
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Portland, OR
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Dallas, TX
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
VA North Texas Health Care System
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Houston, TX
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated:  2/8/2017
mi
from
Bellevue, WA
Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events
Status: Enrolling
Updated: 2/8/2017
Overlake Hospital Medical Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus, Question 3
Status: Enrolling
Updated:  2/9/2017
mi
from
Baltimore, MD
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus, Question 3
Status: Enrolling
Updated: 2/9/2017
Univerisity of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Status: Enrolling
Updated:  2/9/2017
mi
from
Kansas City, MO
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Status: Enrolling
Updated: 2/9/2017
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Status: Enrolling
Updated:  2/9/2017
mi
from
Kansas City, MO
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
Status: Enrolling
Updated: 2/9/2017
Truman Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Status: Enrolling
Updated:  2/9/2017
mi
from
Chicago, IL
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Status: Enrolling
Updated: 2/9/2017
Northwestern University preventive Cardiology Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Newark, DE
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Christiana Care Health Services, Inc
mi
from
Newark, DE
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Atlanta, GA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Boston, MA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Boston, MA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Boston, MA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
West Roxbury, MA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Boston VA Healtcare System
mi
from
West Roxbury, MA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
St. Louis, MO
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Saint Louis University Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
St. Louis, MO
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Durham, NC
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Lumberton, NC
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Southeast Regional Medical Center
mi
from
Lumberton, NC
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Cleveland, OH
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Metro Health System
mi
from
Cleveland, OH
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Lancaster, PA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Lancaster Heart and Stroke Foundation
mi
from
Lancaster, PA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Philadelphia, PA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Jefferson Medical College
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Philadelphia, PA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Philadelphia, PA
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
University of Pennsylvaina
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Houston, TX
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Michael Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Murray, UT
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Salt Lake City, UT
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Salt Lake City, UT
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Utah VA Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Burlington, VT
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Chicago, IL
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Baltimore, MD
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Rochester, MN
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Cleveland, OH
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated:  2/14/2017
mi
from
Cleveland, OH
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Functional Impact of GLP-1 for Heart Failure Treatment
Status: Enrolling
Updated: 2/14/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated:  2/16/2017
mi
from
Louisville, KY
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated:  2/16/2017
mi
from
Boston, MA
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated:  2/16/2017
mi
from
Ann Arbor, MI
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
University of Michigan Internal Medicine Cardiology, Pulmonary Hypertension Program
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated:  2/16/2017
mi
from
St. Louis, MO
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
Washington University School of Medicine - Center for Advanced Med
mi
from
St. Louis, MO
Click here to add this to my saved trials
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated:  2/16/2017
mi
from
Cincinnati, OH
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
Status: Enrolling
Updated: 2/16/2017
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials